ASX - By Stock
|
TLX |
Re:
review of radiopharma companies
|
|
energyraters
|
9 |
2.4K |
2 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
9
|
2.4K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
review of radiopharma companies
|
|
energyraters
|
9 |
2.4K |
0 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
9
|
2.4K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
2 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
496
|
162K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
2 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
496
|
162K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
2 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
496
|
162K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
3 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
4 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
4 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
1 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
1 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Trivia: Duran Duran’s Andy Taylor Claims New Drug Lutetium-177 Is Helping Him Arrest Stage 4 Cancer
|
|
energyraters
|
9 |
2.2K |
1 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
9
|
2.2K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Half Year Results and Investor Conference Call Details
|
|
energyraters
|
20 |
6.5K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
20
|
6.5K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Trivia: Duran Duran’s Andy Taylor Claims New Drug Lutetium-177 Is Helping Him Arrest Stage 4 Cancer
|
|
energyraters
|
9 |
2.2K |
1 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
9
|
2.2K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Trivia: Duran Duran’s Andy Taylor Claims New Drug Lutetium-177 Is Helping Him Arrest Stage 4 Cancer
|
|
energyraters
|
9 |
2.2K |
1 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
9
|
2.2K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Trivia: Duran Duran’s Andy Taylor Claims New Drug Lutetium-177 Is Helping Him Arrest Stage 4 Cancer
|
|
energyraters
|
9 |
2.2K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
9
|
2.2K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
energyraters
|
987 |
452K |
1 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
987
|
452K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
LDX Chart
|
|
energyraters
|
1.7K |
362K |
0 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
1.7K
|
362K
|
0
|
|
ASX - By Stock
|
LDX |
Re:
LDX Chart
|
|
energyraters
|
1.7K |
362K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
1.7K
|
362K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
3 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
energyraters
|
987 |
452K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
987
|
452K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
1 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
496
|
162K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Cancer screening with full-body MRI scans and a seminar on the field of radiology.
|
|
energyraters
|
29 |
8.1K |
1 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
29
|
8.1K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Competition
|
|
energyraters
|
254 |
116K |
1 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
254
|
116K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Cancer screening with full-body MRI scans and a seminar on the field of radiology.
|
|
energyraters
|
29 |
8.1K |
5 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
29
|
8.1K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Cancer screening with full-body MRI scans and a seminar on the field of radiology.
|
|
energyraters
|
29 |
8.1K |
1 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
29
|
8.1K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
4 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
496
|
162K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
3 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
496
|
162K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
3 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
496
|
162K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Cancer screening with full-body MRI scans and a seminar on the field of radiology.
|
|
energyraters
|
29 |
8.1K |
3 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
29
|
8.1K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
2 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
496
|
162K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
4 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
496
|
162K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
2 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
496
|
162K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Cancer screening with full-body MRI scans and a seminar on the field of radiology.
|
|
energyraters
|
29 |
8.1K |
3 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
29
|
8.1K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
1 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
496
|
162K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Cancer screening with full-body MRI scans and a seminar on the field of radiology.
|
|
energyraters
|
29 |
8.1K |
2 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
29
|
8.1K
|
2
|
|
ASX - By Stock
|
TLX |
Cancer screening with full-body MRI scans and a seminar on the field of radiology.
|
|
energyraters
|
29 |
8.1K |
4 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
29
|
8.1K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
9 |
12/08/23 |
12/08/23 |
ASX - By Stock
|
496
|
162K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
6 |
12/08/23 |
12/08/23 |
ASX - By Stock
|
496
|
162K
|
6
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Application for quotation of securities - LDX
|
|
energyraters
|
5 |
1.6K |
4 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
5
|
1.6K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: First Patient Dosed in Phase 3 Illuccix China Study
|
|
energyraters
|
13 |
4.0K |
1 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
13
|
4.0K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives Research & Development Tax Rebate
|
|
energyraters
|
39 |
7.9K |
1 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
39
|
7.9K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
1 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
496
|
162K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
energyraters
|
496 |
162K |
2 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
496
|
162K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives Research & Development Tax Rebate
|
|
energyraters
|
39 |
7.9K |
1 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
39
|
7.9K
|
1
|
|